Navigation Links
3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
Date:9/25/2008

data which demonstrates that an once a week injection of 36,000 IU high-dose EPIAO is as effective as the three times per week 10,000 IU low-dose EPIAO in treating cancer patients with chemotherapy-induced anemia. If approved, high-dose EPIAO will provide patients and physicians in China with a new, safe and more convenient treatment of anemia resulting from chemotherapy. Furthermore, we believe that the greater convenience provided by high-dose EPIAO treatment versus existing treatment options will be a key factor in helping to fuel the growth of the highly under-penetrated oncology market in China."

About the Phase III Data

The Phase III study was a multi-center, randomized, active-controlled trial that enrolled 206 non-myeloid malignant tumor patients. The testing group, including 104 patients, was given 36,000 IU EPIAO subcutaneously once a week for eight weeks. The control group, including 102 patients, was given 10,000 IU EPIAO three times a week for eight weeks. The primary endpoint of the study was the improvement of the Hemoglobin level for > 1-2 g/dL compared to the baseline level. The trial result shows that 70% of patients on high- dose EPIAO injections had Hemoglobin improvement of at least 1-2 g/dL from baseline level, similar to those receiving three times per week dosing of 10,000 IU EPIAO. In addition, the patients were assessed with the peak Hemoglobin value, the nadir of Hemoglobin value, the time it took for the Hemoglobin level to increase for more than 1g/dL and 2g/dL, and the need for blood transfusion for each group. There was no significant difference between the two groups in these secondary endpoints.

In addition, the safety of high-dose EPIAO was comparable to the 10,000 IU EPIAO. The most common adverse effect related to high-dose EPIAO was low fever. The patients recovered within a short period of time.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researc
'/>"/>

SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
4. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
5. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
6. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
8. 3SBio Inc. Announces Change to the Board of Directors
9. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
11. 3SBio Inc. Approves Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2015)... , ... July 25, 2015 , ... ... its refractometer series. It precisely checks and adjusts the surface temperature of the ... , In the pharmaceutical industry, data traceability and documentation are key requirements. It ...
(Date:7/24/2015)... YORK , July 24, 2015 ... following equities: PDL BioPharma Inc. (NASDAQ: PDLI ), ... (NASDAQ: STEM ), Northwest Biotherapeutics Inc. (NASDAQ: ... ). Free research report on PDL BioPharma can be ... 2015, the NASDAQ Composite ended at 5,146.41, down 0.49%, ...
(Date:7/24/2015)... 2015 Origin Agritech Limited (NASDAQ GS: SEED) ("Origin", ... China , today announced that the Company ... ended June 30, 2015, before the market opens on Wednesday, ... teleconference on August 5th, 2015, at 9:00 a.m. ET / ... the results. To participate in the call, please dial the ...
(Date:7/24/2015)... ... July 24, 2015 , ... ... solution, indispensable to any modern scientific or pharmaceutical laboratory. FreezerPro® is an ... Users know precisely where a sample is located even before opening the ...
Breaking Biology Technology:It’s T-Time for Refractometers: On-site Temperature Check Now Available 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 2Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 2RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 4
... Nektar,Therapeutics (Nasdaq: NKTR ) announced today that ... Markets Focus on Healthcare Conference in New,York at the ... a.m. ET., The presentation and Q&A session will ... posted on the Investor Relations, Events,Calendar section of the ...
... Bionovo, Inc.,(Nasdaq: BNVI ), a leader in the ... of women,s health and cancer, is scheduled to,present at the ... presentation by Tom Chesterman, SVP and CFO of Bionovo, Inc., ... local time at the,Millennium Broadway Hotel in New York City., ...
... 28 RainDance Technologies, Inc.,a developer of ... of Christopher McNary as President and Chief,Executive ... of the,Board, in driving RainDance Technologies, vision ... Laboratory System in the Life,Sciences and other ...
Cached Biology Technology:RainDance Technologies Appoints McNary President and CEO 2RainDance Technologies Appoints McNary President and CEO 3
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/7/2015)... 2015 Research and ... of the "Capacitive Fingerprint Sensors Patent Landscape" ... this date, fingerprint sensing technology is the most ... are well developed. This patent landscape focuses on ... The domain of capacitive fingerprint sensors is closely ...
(Date:7/2/2015)... , June 25, 2015 ... of the "Next Generation Biometrics Market by Application, ... report to their offering. The next ... by 2020, at a CAGR of 17.9% between 2015 ... leading application for the market. Safran SA ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... Plant Industry scientists and international collaborators have discovered the ... epidemic years cost wheat growers worldwide in excess of ... the prestigious journal Science , scientists from CSIRO ... Maize and Wheat Improvement Center have identified a wheat ...
... haematologist Professor Christopher Baum and his colleagues Dr. Ute ... Ursula M. Hndel Animal Welfare Prize. The prize was ... School (Medizinische Hochschule Hannover, MHH) in recognition of their ... gene therapies that significantly reduces the number of animal ...
... children can be expensive, time-consuming for clinicians, and tedious for ... a large number of blood draws. A new calculation eliminates ... that can be performed in a clinical setting to offer ... new estimate formula, developed from a study that will appear ...
Cached Biology News:Saving wheat crops worldwide 2Reducing animal experiments through top-class research 2Reducing animal experiments through top-class research 3Updated formula measures kidney function more accurately 2Updated formula measures kidney function more accurately 3
Standard 2" or 3" Plastic can be ordered with 81 or 100 cell dividers. Mini 2" Plastics Boxes come standard with 25 cell dividers. Plastic boxes can also be ordered with corresponding freezer racks...
Request Info...
5-bromouridine 5'-triphosphate (BrUTP) *10 mM in TE buffer*...
Estrogen Receptor (ER) Competitor Assay Kits Green for Estrogen Receptors-alpha and -beta (ER-Alpha and ER-Beta) are ideal for screening novel estrogen receptor binding compounds and endocrine disrup...
Biology Products: